Adam Koppel, M.D., Ph.D.

Senior Vice President, Chief Strategy Officer
Biogen Idec

Dr. Koppel joined Brookside Capital in 2003 and is a Managing Director. Prior to joining Brookside Capital, he was an Associate Principal with McKinsey & Company where he consulted to companies in the pharmaceutical and biotechnology industries. Dr. Koppel received an M.D. and Ph.D. from the University of Pennsylvania School of Medicine, an M.B.A. from the Wharton School of the University of Pennsylvania, and a B.A. from Harvard University.